Cimavax - a lung cancer vaccine

Bookmark and Share
Published: 6 Jan 2017
Views: 2388
Rating:
Save
Dr Danay Saavedra - Centro de Inmunología Molecular, CIM, Cuba

Dr Saavedra speaks with ecancertv at the ecancer Colombian Cancer Congress about a novel anti-cancer vaccine, Cimavax.

She describes the immuno-targeting of the vaccine against EGF, and how blocking this pathway can halt cancer cell cycle progression.

Considering results from phase III studies, in treating advanced non-small cell lung cancer patients, Dr Saavedra reports a significant benefit for patients expression high levels of EGF.